Skip to main content
. 2021 May 21;11:10727. doi: 10.1038/s41598-021-90246-y

Table 5.

Subgroup analysis in the propensity-score matched corticosteroid group.

Initial dose of methylprednisolone (N = 106) Administration period (N = 118) Timing of corticosteroids initiation (N = 118)
Pulse/semi-pulse Standard dose  ≤ 10 days  > 11 days On day 1 on day 2 or 3
(N = 30) (N = 76) (N = 55) (N = 63) (N = 70) (N = 48)
Time to PCR negativity of the swab solution
Median [IQR]—days 22 [15, 24] 15 [9, 24] 15 [8, 24] 21 [14, 26] 15 [9, 24] 20 [15, 27]
Hazard ratio (95%CI) 0.854 (0.537–1.358) 1.437 (0.968–2.132) 0.753 (0.504–1.124)
p-value 0.505 0.072 0.165
Duration of fever
Median [IQR]—days 8 [4, 16] 10 [5, 19] 6 [4, 15] 11 [6, 28] 8 [4, 15] 10 [4, 19]
Hazard ratio (95%CI) 1.037 (0.639–0.1.683) 1.337 (0.886–2.019) 0.927 (0.610–1.407)
p-value 0.882 0.167 0.720
Time to improvement in radiological findings
Median [IQR]—days 11 [4, 23] 8 [6, 16] 7 [5, 14] 9 [6, 18] 7 [5, 16] 8.5 [6, 18]
Hazard ratio (95%CI) 0.880 (0.554–1.399) 1.124 (0.760–1.662) 0.855 (0.576–1.271)
p-value 0.589 0.557 0.439
Invasive mechanical ventilation—No. (%) 17 (56.7) 17 (22.4) 9 (16.4) 31 (49.2) 18 (25.7) 22 (45.8)
Duration of invasive mechanical ventilation
Median [IQR]days 8 [6, 10] 15 [10, 26] 10 [8, 16] 11 [8, 18] 10 [7, 13] 11.5 [9, 23]
Hazard ratio (95%CI) 2.831 (1.347–5.950) 1.247 (0.588–2.646) 0.713 (0.374–1.358)
p-value 0.006 0.565 0.304
Mortality—No. (%)
On day 14 2 (6.7) 5 (6.6) 5 (9.1) 2 (3.2) 3 (4.3) 4 (8.3)
On day 28 4 (13.3) 6 (7.9) 6 (10.9) 6 (9.5) 6 (8.6) 6 (12.5)
During the entire observation period 4 (13.3) 8 (10.5) 7 (12.7) 7 (11.1) 6 (8.6) 8 (16.7)

Categorical variables were presented as numbers (percentages). Continuous variables related to time were presented as median [interquartile ranges]. Cox proportional hazards model was used to calculate the hazard ratio and its 95% confidence interval for the treatment effect between groups. A p value of < 0.05 was considered statistically significant. IQR, interquartile ranges; CI, confidence interval; PCR, polymerase chain reaction.